SelectQuote, Inc. (SLQT) Earnings Call Transcript & Summary

February 24, 2021

New York Stock Exchange US Financials Insurance conference_presentation 45 min

Earnings Call Speaker Segments

Daniel Grosslight

analyst
#1

All right. Sorry for the -- little bit of a late start here. Some technical difficulties on our end, but we got it all figured out. Good afternoon, everyone, and thanks for joining us today for the SelectQuote fireside chat here at the Citi Healthcare Services Conference. My name is Daniel Grosslight, and I'm the health care technology analyst here at Citi. And I'm very pleased to welcome here the SelectQuote management team. From the company, we have CEO Tim Danker and CFO Raff Sadun. Now we'll get into this a little bit later. But from my perspective, SelectQuote is sitting at the intersection of some very interesting and strong secular tailwinds; namely the growth in Medicare Advantage and the shift to more DTC distribution within insurance. And in my mind, SelectQuote presents a very compelling way to play some of these themes. But there's certainly been a lot of controversy around this space, and I'm sure we'll get into this a little bit later. We should have a good discussion around the competitors and how SelectQuote differentiates. We want this fireside chat to be more conversational than just me on the screen talking at you. So please feel free to e-mail me at daniel.grosslight@citi.com any questions, and I'll ask on your behalf. [Operator Instructions] So Tim, before we dig into the Q&A, SelectQuote is still relatively new to the public markets, having gone public just last May. A few quarters under your belt now as a public company. And as I mentioned, there's some controversy around the space. So I think it would be helpful for those listening in who's not -- who are not too familiar with the SelectQuote story to do a little bit of table setting. Just give us a little bit of background on the SelectQuote story and how you differentiate from the other DTC insurance comparison platforms out there.

Timothy Danker

executive
#2

Sure. I'd be happy to do so, Daniel. Raff and I really appreciate the opportunity to be here, and thanks to Citi for hosting the event. So just briefly on the history, we're a leading, tech-enabled direct-to-consumer distribution platform. We've actually been around for 35 years, dating back to pioneering the first direct-to-consumer sale of term life, 1985. And while we're a diversified multiline platform, we have intentionally kind of doubled and tripled down in the Medicare market, given the long tail of opportunity. I think most who are on this call know there's been significant growth in the number of eligible Medicare beneficiaries, over 60 million today, growing to projected 75 million over the next 7 or so years; significant growth in the popularity of Medicare Advantage; both CMS and MCOs citing 10% or better growth for the past several years. And obviously, we've had some success growing at significant multiples of those growth rates as there's a secular shift to direct-to-consumer models like ours. I think we would attribute part of the success and your question around differentiation on 2 points. One, we're big believers in -- that this model still needs highly skilled agents and purpose-built technology. And it's those things working in tandem that we think delivers not only the best customer experience but also helps maximize our LTV. So maybe to double-click on those for a minute. On the agent front, we have made significant investments in our professional inside sales force. We think it's mission-critical given the complexities of the products that we're distributing and, quite frankly, the recurring revenue that's at stake if you can do it right. So our approach has been to build a 100% internal agent force. We've built it from the ground up. We're not using external sales centers like some of our competitors. We're recruiting. We're training. We're providing continuous education, really with the end goal in mind to build a career opportunity. That's really what we're trying to do. We've got a merit-based leveling system that allows for leading incomes. We retain over 90% of our top agents. And this combined with technology is really what's driving a lot of the policy growth and agent productivity you may have heard about in our most recent earnings call. On the technology point, briefly, it is indeed purpose-built. The vast majority of it is proprietary, custom built, and we utilize it from everything to how we recruit and train our agents across the country via SelectQuote University; to the marketing tech that really we're utilizing to acquire, to score, to distribute our agents to try to squeeze out every available dollar of our marketing ROI; to the tools that sit on the agent desktop that are critical for matching doctors and drugs to find the best plan across our robust carrier platform. And that's obviously important to driving LTVs that again lead the industry. And then finally, we use it on the back end, too, our customer care organization for ongoing dialogue and planned fit with the consumer -- and we'd point to our 25% improvement in recapture rate -- as well as providing an opportunity for cross-sell of other products or services, so we would argue a very durable model. Just to brag on our operating team for a minute, not on Raff and I, but our 2Q results for AEP, we grew 127% Senior revenues. We added $67 million of adjusted EBITDA year-over-year. This was our fourth quarter of 100% Senior revenue growth, which is pretty phenomenal. Agent productivity over 32% while having a forklift increase of 70% improvement -- increase in the agent force, that doesn't typically happen to see those types of productivity gains when you're adding that many agents. Senior margins at 43%, rev/CAC north of 3x. We're certainly proud of our LTV. So moving forward, we'd say we are seeing stability in our unit economics and LTVs in a period of rapid growth. And we also -- in addition to the core business, we are not a complacent bunch. We're going to continue to leverage this model: final expense, value-based care initiatives. And we think that this is a great way to leverage this highly effective -- but it is an evolving and flexible customer acquisition machine, if you will.

Daniel Grosslight

analyst
#3

Yes, yes. And some great points in there that we can jump off on. I guess, first, the accounting here, it tends to be a little bit difficult because there are so many assumptions that go into revenue recognition and how that flows down to your financials. But I guess it starts with the LTV, right? And clearly, there's a difference in the LTVs that you book in Medicare in the Senior segment versus your competitors. And I guess that speaks towards that model that you have, that highly trained agent force model, lowering churn, increasing persistency, which flows through your LTV. And then, I guess, combined with that, as you mentioned, about 130% growth in approved members this past AEP while your competitors saw significantly less. So I guess the question is, was there anything you did different this year versus prior years, given COVID, given the election, given all of the operating difficulties some of your competitors have had? And do you expect to see kind of that widening divergence between your results and the rest of the market?

Timothy Danker

executive
#4

Yes. It's a great question, Daniel. I mean I think our ability to achieve this kind of growth really starts with the quality of our build. We've been at this business for a decade. We've been very intentional around how we built our capabilities, not just on front-end customer acquisition but also with respect to the customer experience and retention, the quality of business we're writing for our carrier partners and, ultimately, LTV. So that end-to-end thinking about the entirety of the business model has been with us from the start. I get accused of all of kinds of punny euphemisms, but I like to say we like to nail it before we scale it, and that's exactly what we've done. To be specific for this AEP and the significant [Technical Difficulty] [ noticeable fund and percent ] policy growth, it's a function of the integrated system we've built. It's not one thing, right? It's marketing. It's our workflow. It's our skilled agents. It's our technology. It's our customer care. They're all key. To put it simply, each piece of that business model impacts the whole. I think it's best captured if you look at our 32% increase in agent productivity, despite the sizable increase of our agent force. There's not any -- there's not that many businesses that can do that, but it's because of the way that we built the model that we were able to achieve it. I think as to the how we did it, again, we made investments in the underlying operation. Things like our national hiring, we're now recruiting and have got associates in over 41 states. We virtualized our training via SelectQuote University. I think we released over 80 technology enhancements last year to drive both efficiency in the model as well as ensuring that we have proper plan matching and effectiveness, if you will -- improvements to our coaching model. So all those investments into the engine allowed us to really improve upon lead conversion and policy production. And I'd also say, because of that, it allowed us to lean into the massive market potential that's out there. We did make incremental investments on the marketing front, including some marketing sources like TV that some of our competitors have said they can't make work. To your question on the election, we did -- as well as others in the industry, we felt a little pressure on TV from the election, right? There was a lot of political advertising dollars being spent on TV that did create what I'd call short-term issues on clearing TV ads from breaking news and things of that nature, that put a little bit of pricing pressure. But with that said, we're very pleased with our ability to navigate through that particular stretch of AEP. And I think that it was a function of our engine and our LTVs that allowed us to participate in these channels economically and eyes wide open, and you wouldn't -- we wouldn't have been able to do it if we didn't have the overall business model to support it. I think our decades of experience in off-line media, going back to the '90s, right, helped us navigate, make good decisions. So I think all in all, we executed the plan that we said that we were going to do. We certainly felt in the years prior we had excellent margins, north of 40%, but we left a lot of EBITDA dollars on the table. So part of our express strategy this year has been to grow absolute EBITDA dollars while maintaining solid fundamentals, and we think we hit the mark this past AEP with our 98% growth in EBITDA, and we still kept very attractive margins at 43%. So we're proud of that. I don't think a lot of companies get to say that.

Daniel Grosslight

analyst
#5

Yes, yes. It was certainly an impressive result this past AEP. I guess looking forward to next year's AEP, I guess, at the end of the day, it all comes down to agents. You might have the best technology out there, the biggest integration, but if you don't have the right agents putting seniors into the right policies, it's kind of all for naught. So as you look to ramp up your agent force again for next year's AEP, how many agents do you think you need for next year, or I should say the end of this year, calendar year? And what kind of productivity increases are you expecting out of your existing agents?

Raffaele Sadun

executive
#6

Yes. So maybe I'll take the first part of that and hand it over to Tim in terms of how we recruit the agents. But generally speaking, we don't project increasing levels of agent productivity. Historically, we've actually experienced improving agent productivity. But in terms of forecasting, we always hold that relatively flat. That means that the vast majority of the increase in revenue is going to be driven by incremental agents. And if we do experience agent productivity gains, that would tend to be sort of upside from our sort of expectations. We're not providing specific guidance for fiscal '22 yet. However, we refer back to our medium-term guidance that we gave -- we've been giving for the last couple of quarters. We expect to be able to grow the Senior business at a CAGR of over 40% -- revenue CAGR of over 40% for the next several years with margins in the mid-30s, and consolidated revenue at a CAGR of over 35% with margins in the mid-20s. And so that's with 2020 as a starting point. So obviously, we've been outpacing that growth rate recently. We don't expect that we can continue to grow at 100% going forward. But as you think about the total increase in agent headcount, that we'll be roughly in line with that revenue growth. Tim, anything you want to add in terms of agent recruiting?

Timothy Danker

executive
#7

Yes. I would just say it is definitely -- it's one of the 2 things that, as a management team, we're always waking up worrying about, if you will. It's high-quality people, and it's leads. It's marketing. And to this specific question, we feel great about our ability to recruit the agents we need to deliver the plan. With the onset of COVID, we went to 100% remote hiring, training. We worked in a fully remote environment. As I mentioned, we're hiring across the country now. We've always hired from a diverse background. We're not just looking for licensed agents. So that gives us a lot of flexibility. And despite being fully remote this year, hats off to the team, we exceeded our hiring goals. We were able to train through this virtual platform. We actually retain more of our new hires at every stage gate, those that got licensed, those that started the first day, those that started AEP, those that ended AEP and then, obviously, the productivity gains that we saw. So we see a lot of opportunity here. We're not really concerned about any headwinds there given our approach. And again, we also concentrate on, again, building career opportunity, how we make folks successful. We're very focused on culture. We've been awarded for multiple years, both regional and now nationally, top workplaces awards. So we don't forget about the importance of people in our model.

Daniel Grosslight

analyst
#8

Yes, yes. And one of your competitors has said they're moving more towards a 100% internal agent force. So I get that you've had a lot of success historically in recruitment and retention. Do you think that changes at all as the market for agents becomes more competitive, both on kind of a retention and a wage of new -- the wages of new agents you have to pay out?

Timothy Danker

executive
#9

No, we don't believe so. I mean we've not run into any issues whatsoever in recruiting. And if you've got a strong culture and you have a real career opportunity and you have [ probably ] a good operation and you can embrace that with employees, they love it, and they only want to come work for you. They -- we're a very sticky business, and we really -- there's just so much opportunity that's out there. And we've made intentional build. Like, we maybe weren't as far along a few years ago with respect to our recruiting and talent acquisition. And we've really doubled down on it, and we treat it more as we do professional inside sales and a sales center mentality. And we've got great people on our talent acquisition team. And we feel when you just step back and look at the opportunity at SelectQuote, it's very strong, and our retention and numbers support it.

Raffaele Sadun

executive
#10

And I might just add that we're recruiting people from all walks of life. We're not necessarily recruiting people who are already licensed agents. And so just naturally, that increases the overall pool of people that we can pull from, especially as we're pulling nationally now as well.

Daniel Grosslight

analyst
#11

Yes. Makes sense. Okay. Now turning to LTVs. As I mentioned, you're consistently above your competitors in terms of LTV, which I think is a testament to your platform, to your tech, to your agents, et cetera. But you've noted going forward, you're not projecting much uplift in LTVs. I would have thought just given how commission rates out of -- for Medicare Advantage have trended recently, plus 5%, plus 6%, that you would get a natural uplift just from the increase in CMS-dictated commissions. But apparently that's not what you're projecting. Is there some -- are there some puts and takes around the MA LTV projections that are embedded in there, maybe some more churn from more recent cohorts? Can you walk us through the puts and takes around that LTV projection?

Raffaele Sadun

executive
#12

Yes. Great -- that's a great question. I mean let's take a step back and talk about the key drivers of LTV, right? So it's persistency. It's commission rates. It's the mix of switcher versus new. It's a mix of carriers, fall-off rates, intrayear lapse rates, constraint. I mean there's lots of drivers that go into it. One of the biggest ones is persistency. And the persistency rates that we use are based on a 36-month weighted average by carrier based on historical experience. So as we've been growing rapidly, there's more of a weight put on more recent experience. I think we said this last quarter. The persistency assumption has a 90% weighting towards our most recent experience, which was the lower persistency that we saw last year, so the January 2020 event. So while LTVs were flat in the quarter, it was a combination of lower persistency offset by rate and some of the other drivers around carrier mix. As we think about assumptions going forward, we don't necessarily model improving persistency. We sort of hold it flat to what we currently have. And our guidance assumes, certainly for the rest of fiscal '21, that the higher weighting of lower persistency cohorts going forward were basically replacing some of the higher persistency from several years ago. And with the rate increases that we have seen, like that is going to offset a lot of that lower persistency certainly for fiscal '21. With respect to fiscal '22 and the guidance around there, we haven't provided LTV expectations yet with respect to that. We'll do that when we do fiscal '22 guidance, but a lot of that will be driven kind of by what we're seeing right now as part of the January '21 renewal event. And while those figures will continue to bake through the end of March, we are seeing slightly higher first term persistency. And that's up a little bit even in the last couple of weeks. I think on our earnings call, we said it was kind of flat to last year. So it looks like it's up a little bit to last year. Lower second term persistency, which was expected and in line with kind of what we were seeing. And then third term persistency and out is actually flat to above last year. And so if those trends hold, that will start feeding into the calculation. It probably won't start getting into the calculation until the fourth quarter, just because we're selling policies now for the third quarter that are really based on the persistency that we had last quarter as well. But they'll start bleeding in, in the fourth quarter and beyond. And then obviously, because these are 3-year weighted average, it'll take a little bit of time to seed itself in. But from an expectation standpoint, generally speaking, we hold persistency flat to our most recent experience. One of the things that I think is important to remember is that our actual customer persistency, so customer retention, is higher than our 606 persistency, given that we're recapturing a growing number of our customers that are switching carriers. We can do that because the investments we've made in our customer care team that Tim mentioned, that kind of activity actually puts a little bit of pressure on 606 persistency because it's sort of a lost customer with the original carrier, but it's a new customer with that new carrier. So customer persistency is impacted. And on a net dollar perspective, it's actually probably a positive because we get the renewal rates that are in place at that point in time versus when it was originally sold. But it's one of the reasons why we say persistency is an important factor, but it's not the only factor as you think about LTVs, and you really can't just look at one individual metric. You have to sort of have a holistic view of the business. And by the way, as we think about long-term views on LTVs, there can always be a little bit of short-term movement, plus or minus here or there. But long term, there's more tailwinds to the drivers of LTVs than there are headwinds, in our opinion.

Daniel Grosslight

analyst
#13

Yes. That's good to know. And I don't want to spend too much more time on this because you can certainly get kind of wonky and end up kind of banging your head against the keyboard if you get too deep into this accounting. But I guess just going back to that point where, because of your recapture rate, you have -- your persistency for 606 is lower than what the true persistency is, wouldn't that mean that as you collect cash, you're going to just recognize sale revenue because your LTVs are understated?

Raffaele Sadun

executive
#14

Yes. I mean I think -- well, the LTVs are a reflection of 606 persistency, right? I think what ultimately will happen is at the end of that 10-year renewal period, right, there's going to be incremental revenue that comes in because we don't book revenue beyond that 10-year expectation. And anything that comes in beyond that period will basically book -- be booked as revenue as it comes in. And based on the current curves, we still expect that -- at the end of that 10-year period to have roughly 10% of the original book that's still there renewing. And by the time you get that far out in the curve, they're probably renewing in sort of the mid-80s. So none of that is really reflected in our numbers yet.

Daniel Grosslight

analyst
#15

Okay. Got you. All right. Tim, I want to go back to something you said earlier on the marketing and how you've been able to pivot pretty quickly. And maybe some of that is due to your experience in the '90s, et cetera. Very good performance out of your marketing channels this past AEP. Can you go into a little more detail on which channels you saw as most productive this past AEP, and looking forward, how you think that might shift? And maybe detail a little more some of the technology investments you've made in lead acquisition.

Timothy Danker

executive
#16

Okay. Yes. Sure. I'd say overall, there's not one marketing channel that is necessarily most productive. It can and does move over time. Hats off and credit to our COO, Bill Grant. He's a brilliant strategist and marketeer. And I think our strategy has really been to employ this omnichannel approach because we think it's important to be able to economically fish, if you will, in multiple ponds. You don't want to be pigeonholed in. And so we like to have a vast array of approaches from the traditional off-line media that you mentioned, TV and radio, including a lot of capabilities we have in digital. And we have a significant amount of lead flow there from search to SEO to third-party leads, to content-native. We are also growing our strategic partnerships. So that wide-funnel approach has allowed us to consume all kinds of market media. We can adjust on the fly if we experience pressure, that I mentioned an example in the election, in a particular lead source, we can pivot all while managing the all-important kind of revenue to CAC relationship. As to the -- and I think on a go-forward, right, we're going to continue with that type of strategy. And ultimately, having the business that we have, complementing it with agents and tech, et cetera, really allows us to participate in the widest funnel possible. As far as the go-forward investments in marketing tech, we're actually doing quite a bit here from how we're purchasing third-party leads via SelectBid. It's essentially a ping-post platform. It's using predictive analytics to make intelligent real-time buys. Again, on expected rev/CAC, we continue to make a lot of tech investments in data science. We've got a decade-plus of history. We're always trying to improve our algorithms, how to refine our marketing mix and how to really ultimately distribute those leads. We're going to continue to make investments in our proprietary CRM and workflow engine [Technical Difficulty] [ select in it ] at SelectQuote, which makes -- takes these rich leads and scores and efficiently distributes them to the agent force. So I think that's some of the investments. And I'd say those are really only as good as the supporting agent and customer service and the underlying value that we're providing on the platform. But we kind of point to our margins and the rev/CAC multiples we're achieving and LTVs in a period of pretty rapid growth, that we believe that the marketing mousetrap is working.

Daniel Grosslight

analyst
#17

Got it. Got it. Okay. Okay. Now turning to kind of that CAC and LTV dynamic, the unit economics here. You mentioned, historically you were probably leaving some growth on the table because you were more focused on maximizing margin. But for the past year or 2, you've really been kind of going more into growth mode and focusing on the absolute quantum of EBITDA. So as we look at LTV to CAC, we saw that drop from around 4.1x to 3.2x, and adjusted EBITDA per MA/MS policy fell from 43% to 38%. And so as we look forward to calendar year '21 and beyond, how should we think about the unit economics in Medicare and how you maximize growth and titrate profitability?

Raffaele Sadun

executive
#18

Yes. So I think a couple of things worth noting, first of all, the metrics of revenue/CAC multiple, which is a little bit different than some of our competitors, it is an LTM metric, right? So it's basically a 12-month rolling average. So it basically includes last OEP, which is really the first time that we really bet big on the growth opportunity. And volume, obviously, was up significantly but at slightly lower rev/CAC multiples, but we created a lot more absolute EBITDA. So that obviously happened again this quarter. During the quarter, we also made some comments around the mix of business from our choice platform growing faster than some of our pod relationships. And specifically one of the pod relationships, which is structured where they're providing us leads, their branded leads, to close on their behalf. But when they do that, we receive a little bit less revenue when we have a closed transaction. So that percent of the business represented a lower mix of overall business, so -- which meant we had to generate more of our own leads this year. So that also put a little bit of pressure in terms of the rev/CAC just on a year-over-year basis. As we think about the longer-term guidance, I think going back to the guidance we talked about a few minutes ago on the revenue side -- on the Senior side. So revenue growing at a CAGR of 40% with margins in the mid-30s, that would translate into a rev/CAC multiple of 3x or above. And so we do expect basically that to settle out in conjunction with the margins that will settle out into the mid-30s, and that's on an annual basis. So the EBITDA per policy will come down a little bit from maybe where it is now, but then settle out as we maintain those margins. And ultimately, we think that's probably the right balance of mixing absolute revenue and absolute EBITDA dollars at attractive IRR and rates of return and margins, while also balancing the amount of cash that we've used to achieve that growth.

Daniel Grosslight

analyst
#19

Got it. Okay. Very, very helpful. And glad you mentioned cash because I think everyone in this space is focused on that cash and cash burn. Because it is expensive to acquire these seniors, and as you grow, you're burning cash. And I think that's compounded by what we talked about a little earlier, on the opacity of the GAAP accounting here. So you noted on your call that you increased the year 1 cash collection from around 34% last year to 45% this past quarter. Can you remind us how you were able to increase that cash collection in year 1? And when do you expect to be able to break even on a free cash flow basis, knowing that it kind of depends on how you're titrating that growth versus profitability?

Raffaele Sadun

executive
#20

Yes. So yes, on the last earnings call, we mentioned the amount of cash coming from first year revenue items has gone up as a percent of the overall lifetime revenue. In hindsight, we probably used a poor choice of words with respect to how we achieved some of this. I think we said we restructured some of our deals with our carriers. What that really meant was we have new revenue streams with our carriers to deliver value to them, through things like health risk assessments and value-based care, education as well as other services that we can provide them that they're willing to pay us for. And most of those payments end up being upfront. So that drove a big increase in terms of just the mix of cash that's received upfront. It wasn't so much that we restructured the commissioning deals because that was just the structural nature of those. Also, the inclusion of Inside Response year-over-year helped. Inside Response is sort of an advertising business that's really all year 1 cash. So the one thing I think I might highlight is that it's not really from increased marketing development funds associated with the pods. And we touched on this before. The pods definitely grew year-over-year. And actually their relationships with the carriers got more robust. But our choice platform has actually been growing faster than our pod platform has been. And so marketing development funds as a percent of revenue actually represented a lower percent of revenue this year than it did last year. So in total, that sort of ended up with 45% of the revenue being year 1 cash items in our Senior business. On a consolidated basis, it's actually closer to 50%. In terms of the other 55% within the Senior business, so that renewal revenue and how that comes in over that 10-year renewal period, it is front-end weighted, right, just based on the persistency curve. So of the remaining renewal revenue, over 50% of that renewal stream is going to be collected in the first 3 renewal periods. So when you combine sort of the first year revenue and the first 3 renewal periods, we've collected about 75% of the lifetime revenue associated with that policy. And that -- in terms of the first year piece of that, I think that can probably continue to grow a little bit in terms of some of these new initiatives that we're launching on value-based care, which tend to be a little bit more front-end weighted. But it's never really going to get to a 75% upfront and 25% renewal. Just structurally, the way commissions work, I don't really think that's feasible. And from a forecasting perspective, we're not expecting big increases in that percentage, either up or down from where it is now. Relative to EBITDA and cash flow. So I think based on the guidance that we've given, we're probably a few years away from that and a few years beyond that in terms of operating free cash flow, just given some of the working capital dynamics of the business. But I think the growth in the business that we're experiencing is really building a bigger and bigger balance of commission receivables that are very stable. They're producing very attractive rates of return, very consistent. We're talking well over 20%. Some of the cohorts are well over 30%. And so we think that's -- continuing to invest in that kind of growth is probably -- that's in the best interest of our shareholders. And in terms of how do we fund that growth, you may have seen this morning we announced that we've refinanced our credit agreement. We actually secured an additional $290 million of committed capital through an additional $145 million that we received today, so immediately, and then another $145 million in a committed, delayed-draw term loan. And so as part of that, we also lowered our overall interest rate by about 20% to 5.75% and changed some of the covenants to allow us a little bit more operating flexibility. So given the performance of the business over the last 18 months, I think we took advantage of an opportunity that further strengthened the balance sheet while reducing our cost of capital. And I think that just puts us in a stronger position to be able to execute on this huge market opportunity that we see in front of us.

Daniel Grosslight

analyst
#21

Yes. Makes sense. And do you think that, that additional capital raise will get you through cash flow breakeven?

Raffaele Sadun

executive
#22

So again, we're not providing a specific date on that at this point in time. I think that having more capital than we did yesterday is -- puts us in a better position to be able to execute the business. And as we have more visibility in terms of the long-term -- longer-term growth rates and the guidance for fiscal '22, we'll provide that later on in the year.

Daniel Grosslight

analyst
#23

Understood. All right. Now turning away from MA for a quick second. You do have 2 other big segments here, right, Life and Auto & Home. And in the Life segment, you've pointed to some COVID-related weakness in Term as folks can't get to the doctor to get their checkups, which is being offset by some very strong growth in the final expense product. Can you put -- can you talk around -- about the puts and takes around those products in the Life segment? And then in Auto & Home, clearly not an investment priority at this time. So just curious, why keep that around? At some point, are you going to start to reinvest? Could you divest? What are your thoughts around Auto & Home and how that fits into the bigger picture here?

Raffaele Sadun

executive
#24

Maybe I'll touch on term life and then turn it over to Tim to talk about final expense and Auto & Home. But the term life business is one piece of the business that is impacted by COVID, it's a negative way. It's interesting. We're seeing good demand on the front end, but there are conversion issues having to do with people not completing their paramed exams, given that people don't want individuals coming into their homes. They're not keen on visiting outside labs just yet. It's interesting. We saw some improvement last summer, but then it sort of reverted back as COVID cases spiked in the fall and the winter. So I would say that long term, we fully expect the conversion rates to get back to historical levels. But for the short to medium term here, the next couple of quarters, it will probably continue to be impacted by COVID. As a reminder, the term life revenue only represents about 10% of our overall revenue for the business. So while it's a little bit soft right now, it's not a huge driver. Tim, do you want to touch on final expense and Auto & Home?

Timothy Danker

executive
#25

Yes. Maybe first on Auto & Home. I mean we do find this to be an attractive market. It has an extremely large addressable market, great cross-sell opportunity for Senior and Life. Our decision around kind of tapping the brakes on that was ROI-driven: where are we going to invest next dollar. We've got several attractive market opportunities, obviously Senior with a 2- to 3-year payback in margins, north of 35%. Our final expense business, I can touch on with a 1-year cash flow breakeven and 30% margin plus. SQAH, on the other hand, right, had margins in the, call it, mid-20s with a payback that was 4 years-ish. So we're going to continue to optimize the Auto & Home model. We're going to try to improve, pull in the cash consumption required. But we do think there is opportunity there. And if those optimizations take place, then we can be back trying to grow that particular business. On the final expense, I'm glad you brought it up, Dan, because folks, analysts tend to parse through our Life business to understand the term business that Raff talked about versus final expense. Both attractive, but final expense is in huge growth mode. We've sized it up using [ LIMRA ] data to be an upwards of $10 billion addressable market opportunity. There's a real consumer need here for a basic death benefit via simplified to no medical underwriting type of proposition. You've seen our growth trajectory, which has been very solid, and it's, quite frankly, a market that we think is ripe for disruption. It's typically been sold in legacy field agent models, sometimes in a single carrier or limited choice models and look to our experience in Medicare in what we've done there. And we think a robust choice platform, robust marketing technology, our 35-year history in Life business, right, gives us a very unique position, a first-mover advantage. And so we're going to continue to grow. It grew nearly 230% last quarter, 179% fiscal '20 over '19. We talked a little bit about the unit economics being very attractive. And then lastly, there's a lot of synergies between final expense and Medicare. About half of our FE customers are aged 65 plus. So they're ripe for cross-sell opportunities between FE and Senior. And as such, we've built technology integration and since we've launched this cross-sell effort since June, we're sending over, call it, 1,000 transfers a month from final expense to senior. We're converting over 10% into Medicare Advantage or supplement plans, effectively at a 0 CAC. So more to come there. There's more opportunity there, and we're going to continue to lean into that segment, both from a pure-play growth as well as cross-sell.

Daniel Grosslight

analyst
#26

Got you. Very interesting. All right. We are running up on the end of time here, but I would be remiss not to ask you about one of the major initiatives that you recently announced in Medicare, and that's value-based care. And I think everyone is trying to read the tea leaves a little here because it's not -- at least to me, it's not entirely clear what the economic model here is. But it does sound like it's leading to better unit economics and more cash upfront, I should say. So I'd love to hear more about the value-based care initiative that you've been rolling out recently and some of the new hires that you've made on the Medicare side of things.

Timothy Danker

executive
#27

Sure. And we tend to not be very cagey, right? We try to be very transparent, but this is something that, right, is emerging. It's good to see, Daniel, people are reading our press releases, and we are indeed continuing to build health care expertise in the company. We recently added 2 executives, Heidi Robertson-Cooper, Scott Dikeman, senior leaders to our company. They bring a lot of experience, contacts, expertise in health care, and they're going to help us around our strategy. We want to be an important component of the movement towards value-based care. We think this is great for consumers to achieve better health outcomes. That's what we've seen in the clinical data through these more proactive, high-quality care interactions. So we have aligned with numerous care providers around the country in order for us to educate our customers about the benefits of these models, and if they're qualified, ensure they have access to it. So we've announced one VBC partnership publicly. We have 4 additional partnerships in place. We're working on others. And we care about it because it's missionary for us. It's -- right? There's clearly health benefits for the end consumer. There's benefits to both us and to the carrier in terms of better persistency. And we'll be able to share more about what I'll just call this emerging revenue model. At the end of the day, right, we're sitting here, I would argue as center pivot, being an educator and adviser to improve health care literacy. We're leveraging our investments in technology, our customer care organization to provide consumers education on value-based care, eligibility awareness. And then once the -- if they're qualified, we hand it off to our partners who are experts in the actual fundamental care. So at the end of the day, it's just the latest way that SelectQuote is thinking about, I would say, holistically, about our customers and how we can add more value. So stay tuned. There'll be more to come on this topic in the very near future.

Daniel Grosslight

analyst
#28

All right. I will be waiting with bated breath here, because it is an interesting new revenue stream. And I'm encouraged to see that you guys are playing an important role in value-based care because it's, as you know, where the market needs to head. All right. So we are out of time now. I really appreciate everyone joining today and learning more about the SelectQuote story. And Tim and Raff, I appreciate you joining us this afternoon. With that, have a good rest of your day. Take care, everyone.

Raffaele Sadun

executive
#29

Thanks.

Timothy Danker

executive
#30

Thanks for the opportunity, Daniel. Bye-bye.

Daniel Grosslight

analyst
#31

Thank you.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete SelectQuote, Inc. transcript — plus 251,000+ transcripts from 12,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to SelectQuote, Inc. earnings transcripts and 251,000+ others is available through the EarningsCalls.dev REST API. Plans from $24.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.